Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-08

Clinical Trial Update: Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood [Phase 3]

View source ↗

Summary

Phase 3 trial update on efficacy and safety of lanthanum for controlling serum phosphate in subjects with end-stage renal disease requiring treatment for high p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lanthanum (lanthanum)

Snippet

Sponsor: Shire | Conditions: Kidney Failure, Chronic | Phase 3 | Status: COMPLETED